FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using "Universal Acting" Fibroblast Based Immunotherapy

By In The News
February 17, 2021 in The Headlines

Recommended Posts

In The News

Posted February 17, 2021

- Share

Posted February 17, 2021

HOUSTON, Feb. 17, 2021 /PRNewswire/ -- FibroGenesis, a clinical stage company developing fibroblast-based therapeutic solutions for unmet medical needs, announced today new data supporting utilizing its fibroblast-based immunotherapy for successful inhibition and induction of regression...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  219982
2. Jaydee
  16830
3. Kip Powick
  12225
4. deicer
  12196
5. dagger
  9595
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  270.3k
- Total Posts
  
  559k

Sign In

FibroGenesis Reports Positive Preclinical Data in Pancreatic and Breast Cancer Using "Universal Acting" Fibroblast Based Immunotherapy

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support